Bloomage BioTechnology Corporation Limited (688363.SS)
688363.SS Stock Price Chart
Explore Bloomage BioTechnology Corporation Limited interactive price chart. Choose custom timeframes to analyze 688363.SS price movements and trends.
688363.SS Company Profile
Discover essential business fundamentals and corporate details for Bloomage BioTechnology Corporation Limited (688363.SS) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Chemicals - Specialty
IPO Date
12 Nov 2019
Employees
4.44K
CEO
Yan Zhao
Description
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.
688363.SS Financial Timeline
Browse a chronological timeline of Bloomage BioTechnology Corporation Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 27 Aug 2025
EPS came in at ¥0.25 falling short of the estimated ¥0.52 by -52.17%, while revenue for the quarter reached ¥1.18B , missing expectations by -29.08%.
Dividend declared on 14 Jul 2025
A dividend of ¥0.11 per share was announced, adjusted to ¥0.11. The dividend was paid on 14 Jul 2025.
Earnings released on 25 Apr 2025
EPS came in at ¥0.21 falling short of the estimated ¥0.63 by -66.67%, while revenue for the quarter reached ¥1.08B , missing expectations by -27.97%.
Earnings released on 27 Feb 2025
EPS came in at -¥0.41 falling short of the estimated ¥0.28 by -246.43%, while revenue for the quarter reached ¥1.50B , missing expectations by -16.70%.
Earnings released on 30 Oct 2024
EPS came in at ¥0.04 falling short of the estimated ¥0.28 by -85.71%, while revenue for the quarter reached ¥1.06B , missing expectations by -18.81%.
Earnings released on 23 Aug 2024
EPS came in at ¥0.70 surpassing the estimated ¥0.64 by +9.37%, while revenue for the quarter reached ¥1.43B , missing expectations by -1.33%.
Dividend declared on 8 Aug 2024
A dividend of ¥0.38 per share was announced, adjusted to ¥0.38. The dividend was paid on 8 Aug 2024.
Earnings released on 30 Apr 2024
EPS came in at ¥0.51 , while revenue for the quarter reached ¥1.35B .
Earnings released on 29 Feb 2024
EPS came in at ¥0.15 falling short of the estimated ¥0.89 by -83.15%, while revenue for the quarter reached ¥1.83B , beating expectations by +2.01%.
Earnings released on 30 Oct 2023
EPS came in at ¥0.19 surpassing the estimated ¥0.03 by +605.53%, while revenue for the quarter reached ¥1.15B , missing expectations by -27.89%.
Earnings released on 29 Aug 2023
EPS came in at ¥0.46 falling short of the estimated ¥0.63 by -26.98%, while revenue for the quarter reached ¥1.77B .
Dividend declared on 21 Jun 2023
A dividend of ¥0.61 per share was announced, adjusted to ¥0.61. The dividend was paid on 21 Jun 2023.
Earnings released on 29 Apr 2023
EPS came in at ¥0.42 falling short of the estimated ¥0.49 by -14.29%, while revenue for the quarter reached ¥1.31B , missing expectations by -4.58%.
Earnings released on 28 Feb 2023
EPS came in at ¥0.61 surpassing the estimated ¥0.24 by +154.17%, while revenue for the quarter reached ¥2.04B .
Earnings released on 28 Oct 2022
EPS came in at ¥0.42 falling short of the estimated ¥0.87 by -51.72%, while revenue for the quarter reached ¥1.38B , missing expectations by -6.40%.
Earnings released on 20 Jul 2022
EPS came in at ¥0.56 surpassing the estimated ¥0.53 by +5.66%, while revenue for the quarter reached ¥1.68B , beating expectations by +0.06%.
Dividend declared on 16 May 2022
A dividend of ¥0.49 per share was announced, adjusted to ¥0.49. The dividend was paid on 16 May 2022.
Earnings released on 25 Apr 2022
EPS came in at ¥0.42 surpassing the estimated ¥0.34 by +23.53%, while revenue for the quarter reached ¥1.25B , missing expectations by -39.33%.
Earnings released on 26 Feb 2022
EPS came in at ¥0.47 falling short of the estimated ¥1.23 by -61.79%, while revenue for the quarter reached ¥1.94B , beating expectations by +10.02%.
Earnings released on 26 Oct 2021
EPS came in at ¥0.40 surpassing the estimated ¥0.30 by +33.33%, while revenue for the quarter reached ¥1.08B .
Dividend declared on 16 Jul 2021
A dividend of ¥0.41 per share was announced, adjusted to ¥0.41. The dividend was paid on 16 Jul 2021.
Earnings released on 30 Jun 2021
EPS came in at ¥0.44 , while revenue for the quarter reached ¥1.16B .
Earnings released on 29 Apr 2021
EPS came in at ¥0.32 , while revenue for the quarter reached ¥776.68M .
Earnings released on 26 Feb 2021
EPS came in at ¥0.43 , while revenue for the quarter reached ¥1.04B .
Earnings released on 30 Oct 2020
EPS came in at ¥0.36 , while revenue for the quarter reached ¥649.16M .
688363.SS Stock Performance
Access detailed 688363.SS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.